Sawai Group Holdings Co., Ltd., along with its subsidiaries, specializes in the research, development, manufacture, and commercialization of generic pharmaceuticals, primarily serving markets in Japan and the United States. The company's extensive portfolio encompasses a variety of generic medications, available in diverse dosage forms such as tablets, capsules, injectables, and liquid formulations (including syrups, ophthalmic, and nasal solutions). These address numerous therapeutic categories, including cardiovascular, gastro-intestinal, central nervous system, metabolic, anti-infective, anti-allergic, and anti-cancer treatments, in addition to vitamin preparations.